Home LiteratureArticle Details
PMID: 6218795 Published · ppublish English Journal Article

Staphylococcus in toxic shock syndrome and other surgical infections. Development of new bacteriophages.

Archives of surgery (Chicago, Ill. : 1960) ·Vol. 118 ·No. 3 ·1983-03-00 ·Pages 281-4

Altemeier WA, Lewis SA, Bjornson HS, Staneck JL, Schlievert PM

Abstract

Recent studies of Staphylococcus aureus isolates from patients with toxic shock syndrome (TSS) have shown the dominance of phage type 29/52 with the capacity to produce pyrogenic exotoxin C and enterotoxin F. They also showed that 29% of the isolates were nontypable and 90% of them had similar toxigenic properties. The existence of unknown and important phages in this disease was postulated. Five new phages were then developed and used for typing three groups of staphylococcal isolates: 236 from patients with TSS, 67 from patients without TSS, and 159 from patients with infected burns. Results showed a high correlation between the lytic action of the new phages and the 29/52 phages, and an additional typing capability in 35% of the previously nontypable TSS isolates, emphasizing further the potential of bacteriophage typing of S aureus in these infections.

MeSH Terms
Bacteriophage Typing Female Humans Shock, Septic/microbiology Staphylococcus Phages Staphylococcus aureus/classification Surgical Wound Infection/microbiology
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Altemeier W A
Lewis S A
Bjornson H S
Staneck J L
Schlievert P M
Article Info
Journal
Archives of surgery (Chicago, Ill. : 1960)
Abbr.
Arch Surg
ISSN
0004-0010
Published
1983-03-00
Pages
281-4
Language
English
Region
United States
NLM ID
9716528
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]